Previmed MVZ GmbH Gesundheitsforum fuer Kinder und Jugendmedizin
- Address
- Roemerstrasse 32, 82205 Gilching, Germany
Previmed MVZ GmbH Gesundheitsforum fuer Kinder und Jugendmedizin
Previmed MVZ GmbH Gesundheitsforum fuer Kinder und Jugendmedizin is a specialized pediatric healthcare center focused on advancing clinical research in children and adolescent medicine. The center demonstrates particular expertise in infectious disease prevention through vaccine development and immunogenicity studies targeting vulnerable pediatric populations.
- Meningococcal infection prevention and vaccine research
- Pediatric immunology and vaccine safety evaluation
- Multi-serogroup meningococcal vaccine development studies
The center actively participates in comparative vaccine trials evaluating the safety, reactogenicity, and immune response of next-generation meningococcal vaccines. Their research infrastructure supports comprehensive assessment of vaccine formulations against multiple meningococcal serogroups (A, B, C, W, and Y), contributing valuable data on immunogenicity across different bacterial strains and helping to protect children and adolescents from potentially life-threatening infections.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 25 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Previmed MVZ GmbH Gesundheitsforum fuer Kinder und Jugendmedizin
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Safety, Tolerability, and Immunogenicity of MenABCWY-2nd Gen Vaccine in Healthy Infants with Meningococcal Infections | GlaxoSmithKline Biologicals | Phase I | Not Recruiting | Nov 2021 | Nov 2025 |
IMP list
lock Showing 1 of 25 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| GSKVX000000017986 | 1 | Unknown | 2021-11-29 | 2021-11-29 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.